Relevant Entities and Individuals Clause Samples
Relevant Entities and Individuals. FMC Turkey was a wholly owned subsidiary of FMC under the responsibility of FMC’s EMEA Division. FMC operated in Turkey through FMC Turkey, and FMC Turkey provided FMC services and products in Turkey. FMC Turkey and its employees were “agents” of an issuer within the meaning of the FCPA, Title 15, United States Code, Section 78dd-1(a).
Relevant Entities and Individuals. FMC Portugal was a wholly owned subsidiary of FMC under the responsibility of FMC’s EMEA Division. FMC operated in Portugal and Angola, through FMC Portugal. FMC Portugal provided FMC services and products in Portugal and sold FMC products for use in Angola. FMC Portugal and its employees were “agents” of an issuer within the meaning of the FCPA, Title 15, United States Code, Section 78dd-1(a).
Relevant Entities and Individuals. Vitol was a United States company with its principal place of business in Houston, Texas. Vitol was a “domestic concern,” as that term is used in the Foreign Corrupt Practices Act (“FCPA”), Title 15, United States Code, Section 78dd-2(h)(1)(B). Vitol was beneficially owned by a Dutch company named Vitol Holding BV. These companies, together with their affiliates (the “Vitol Group”), formed one of the largest oil distributors and energy commodities traders in the world.
Relevant Entities and Individuals. The Company is a subsidiary of RTX Corporation (“RTX”), a defense contractor. Both Raytheon and RTX are headquartered in Arlington, Virginia. RTX, formerly known as Raytheon Technologies Corporation, is publicly traded on the New York Stock Exchange. RTX is the result of a 2020 merger between Raytheon Company and United Technologies Corporation.
Relevant Entities and Individuals. Olympus Corporation (“Olympus”) was a Japanese corporation headquartered in Tokyo, Japan that manufactured and distributed worldwide commercial photographic equipment and specialized medical imaging and surgical equipment, including endoscopes and microscopes.
Relevant Entities and Individuals. From in or about and between at least 2011 and 2016, Stericycle was a Delaware corporation headquartered in Lake Forest, Illinois. Stericycle ran an international waste management network, focused primarily on medical waste, industrial waste, maritime waste and document destruction. Stericycle had a class of publicly traded securities that were registered with the United States Securities and Exchange Commission pursuant to Section 12(b) of the Securities Exchange Act of 1934 and were traded on the NASDAQ under the ticker “SRCL.” Stericycle was an “issuer,” as that term is used in the Foreign Corrupt Practices Act (“FCPA”), Title 15, United States Code, Sections 78dd-1(a) and 78m(b).
Relevant Entities and Individuals. Defendant Biomet, Inc. (“Biomet”) was incorporated in Indiana with its principal place of business in Warsaw, Indiana and manufactured and sold orthopedic medical devices worldwide. Until September 25,2007, it issued and maintained a class of publicly-traded securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (15 U.S.C. § 781), which traded on the NASDAQ. As such, it was required to file periodic reports with the United States Securities and Exchange Commission under Section 13 of the Securities Exchange Act (15 U.S.C. § 78m). Accordingly, Biomet was an “issuer” within the meaning of the FCPA, 15 U.S.C. § 78dd-l(a). By virtue of its status as an issuer, Biomet was required to make and keep books, records, and accounts which, in reasonable detail, accurately and fairly reflected the transactions and disposition of assets of Biomet and its subsidiaries, including those described below, which were incorporated into the books, records, and accounts of Biomet.
Relevant Entities and Individuals. At all times relevant to this Information, unless otherwise specified:
Relevant Entities and Individuals. BIT Mining, Ltd. (the “Company”) was a cryptocurrency mining company incorporated in the Cayman Islands, with a principal executive office located in Hong Kong. The Company had a class of publicly traded securities that were listed on the New York Stock Exchange (“NYSE”) under the ticker symbol “BTCM.”
Relevant Entities and Individuals. ZYNEX, INC. is a medical device manufacturer incorporated in Nevada with principal place of business in Englewood, Colorado. ZYNEX MEDICAL, INC. is a subsidiary of ZYNEX, INC., incorporated in Colorado, which produces and ships and bills for a medical device, including a product known as the NexWave and associated supplies across the country, including to patients and insurers in Rhode Island. ZYNEX, INC. and its subsidiaries and related entities will hereinafter be referred to as “ZYNEX.”
